Retatrutide Trial Explores Impact on Obesity-Related Chronic Low Back Pain | Retatrutide News

A trial is assessing retatrutide for chronic low back pain in obese or overweight individuals. The study spans 80 weeks and focuses on safety and efficacy.
Clinical Trials · October 16, 2026